MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients

Completed · Not applicable

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to target lesions of the prostate in the bone and to biopsy these lesions using MRI to identify the areas.

Key facts

Study ID

NCT00165386

Run by

Dana-Farber Cancer Institute

People needed

20

Starts

2001-07-01

Expected to finish

2006-01-01

Last updated by the study team

2009-12-09

Who can join

Age: 30 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Histologic diagnosis of prostate cancer
• Bone scan consistent with or suspicious of metastatic prostate cancer within last three months
• Platelet count > 50,000/ul
• PT and aPTT < 1.5 x control
• At least one week removed from taking aspirin or coumadin
• Currently participating in protocol "Collection of Specimens and Clinical Data for Patients with Prostate Cancer or at High Risk for Prostate Cancer"

You may not qualify if…

• Devices incompatible to MR studies (e.g. pacemakers, ear implants, etc.)

Where it is running

• Dana-Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.